MyFinsight
Home
Blog
About
Proceeds from issuance of
long-term debt, net of...
$49,450K
(-49.95%↓ Y/Y)
Proceeds from vendor
financing arrangement
$11,248K
Proceeds from exercise of
stock options
$737K
(-71.21%↓ Y/Y)
Net cash provided by
financing activities
$58,110K
(-75.99%↓ Y/Y)
Canceled cashflow
$3,325K
Net (decrease)
increase in cash, cash...
-$76,971K
(-255.02%↓ Y/Y)
Canceled cashflow
$58,110K
Accounts payable and
other liabilities
$18,963K
(2608.33%↑ Y/Y)
Stock-based compensation
expense
$14,976K
(-36.39%↓ Y/Y)
Prepaid expenses and
other current assets
-$9,484K
(-239.32%↓ Y/Y)
Other non-current
assets
-$4,351K
Depreciation and
amortization expense
$560K
(-44.00%↓ Y/Y)
Non-cash lease expense
$90K
(181.25%↑ Y/Y)
Non-cash interest
expense
$88K
(4300.00%↑ Y/Y)
Maturities of marketable
securities
$24,731K
(-77.04%↓ Y/Y)
Sales of marketable
securities
$14,774K
(74.47%↑ Y/Y)
Repayments under vendor
financing arrangement
$3,325K
Net cash used in
operating activities
-$130,286K
(35.05%↑ Y/Y)
Canceled cashflow
$48,512K
Net cash (used in)
provided by investing...
-$4,795K
(-158.25%↓ Y/Y)
Canceled cashflow
$39,505K
Net loss
-$178,556K
(21.07%↑ Y/Y)
Accretion of premium on
marketable securities
-$233K
(78.41%↑ Y/Y)
Gain on sale of
marketable securities
-$9K
Purchases of marketable
securities
$42,786K
(-59.98%↓ Y/Y)
Purchases of property and
equipment
$1,514K
(45.44%↑ Y/Y)
Back
Back
Cash Flow
Dyne Therapeutics, Inc. (DYN)
Dyne Therapeutics, Inc. (DYN)
source: myfinsight.com